Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BCX 1470 inhibits the esterolytic activity of factor D and C1s (IC50: 96 nM and 1.6 nM), 3.4- and 200-fold better than that of trypsin, respectively.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | BCX 1470 inhibits the esterolytic activity of factor D and C1s (IC50: 96 nM and 1.6 nM), 3.4- and 200-fold better than that of trypsin, respectively. |
Targets&IC50 | Trypsin:326 nM , FD:96 nM , C1s:1.6 nM |
In vitro | BCX 1470 is an inhibitor serine protease. BCX 1470 blocks the esterolytic and hemolytic activities of the complement enzymes Cls and factor D in vitro. |
In vivo | BCX 1470 blocked the development of RPA-induced edema in the rat. |
Molecular Weight | 302.37 |
Formula | C14H10N2O2S2 |
CAS No. | 217099-43-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BCX 1470 217099-43-9 Proteases/Proteasome Serine Protease BCX-1470 BCX1470 inhibitor inhibit